Target N V Biotech Macrogenics Inc (MGNX) insider trading activity

Target N V Biotech is > 10% Shareholder of MACROGENICS INC. Currently has a direct ownership of 9.93 Million shares of MGNX, which is worth approximately $32.4 Million. The most recent transaction as insider was on Oct 02, 2023, when has been sold 150,000 shares (Common Stock) at a price of $4.46 per share, resulting in proceeds of $669,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.93M

0% 3M change

0% 12M change

Total Value Held $32.4 Million

TARGET N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 02 2023	BUY Open market or private purchase	$669,000 $4.46 p/Share	150,000 Added 1.49%	9,929,963 Common Stock
Sep 07 2023	BUY Open market or private purchase	$1,052,000 $5.26 p/Share	200,000 Added 2.0%	9,779,963 Common Stock
Feb 14 2023	BUY Open market or private purchase	$2,535,000 $5.07 p/Share	500,000 Added 4.96%	9,579,963 Common Stock
Jan 19 2023	BUY Open market or private purchase	$795,000 $5.3 p/Share	150,000 Added 1.63%	9,079,963 Common Stock
Dec 27 2022	BUY Open market or private purchase	$1,122,000 $5.61 p/Share	200,000 Added 2.19%	8,929,963 Common Stock
Dec 23 2022	BUY Open market or private purchase	$1,176,000 $5.88 p/Share	200,000 Added 2.24%	8,729,963 Common Stock
Nov 22 2022	BUY Open market or private purchase	$1,788,000 $5.96 p/Share	300,000 Added 3.4%	8,529,963 Common Stock
Oct 24 2022	BUY Open market or private purchase	$1,090,000 $4.36 p/Share	250,000 Added 2.95%	8,229,963 Common Stock
Oct 21 2022	BUY Open market or private purchase	$1,157,500 $4.63 p/Share	250,000 Added 3.04%	7,979,963 Common Stock
Oct 20 2022	BUY Open market or private purchase	$1,143,908 $4.0 p/Share	285,977 Added 3.57%	7,729,963 Common Stock
Oct 19 2022	BUY Open market or private purchase	$623,161 $3.7 p/Share	168,422 Added 2.21%	7,443,986 Common Stock
Nov 19 2021	BUY Open market or private purchase	$3,700,000 $18.5 p/Share	200,000 Added 2.68%	7,275,564 Common Stock
Sep 29 2021	BUY Open market or private purchase	$2,047,000 $20.47 p/Share	100,000 Added 1.39%	7,075,564 Common Stock
Sep 28 2021	BUY Open market or private purchase	$2,064,000 $20.64 p/Share	100,000 Added 1.41%	6,975,564 Common Stock
Sep 17 2021	BUY Open market or private purchase	$3,986,000 $19.93 p/Share	200,000 Added 2.83%	6,875,564 Common Stock
Sep 16 2021	BUY Open market or private purchase	$8,376,000 $20.94 p/Share	400,000 Added 5.65%	6,675,564 Common Stock
Jun 21 2021	BUY Open market or private purchase	$1,630,500 $21.74 p/Share	75,000 Added 1.18%	6,275,564 Common Stock
Jun 16 2021	BUY Open market or private purchase	$2,104,000 $21.04 p/Share	100,000 Added 1.59%	6,200,564 Common Stock
Jun 15 2021	BUY Open market or private purchase	$1,539,750 $20.53 p/Share	75,000 Added 1.21%	6,100,564 Common Stock

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

RDUS

Radius Health, Inc. Healthcare

> 10% Shareholder

TNV